ALKROS1,STAT3SHP2

Andreas Postlmayr1, Astrid Sanchez Bergman1, Jacob Torrejon Diaz2

  • 1Translational Brain Tumor Research, Division of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.

Cell reports
|March 6, 2026
PubMed
概括

ALK和ROS1的融合驱动婴儿类型半球质瘤 (IHG). 这项研究揭示了融合特异性功能和STAT3激活,确定了SHP2与ROS1融合的相互作用,用于潜在的儿科质瘤疗法.